Compare IBRX & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | EXK |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | N/A | N/A |
| Metric | IBRX | EXK |
|---|---|---|
| Price | $2.32 | $9.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $9.83 | ★ $11.69 |
| AVG Volume (30 Days) | 9.5M | ★ 10.5M |
| Earning Date | 11-04-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $82,555,000.00 | ★ $337,137,000.00 |
| Revenue This Year | $629.94 | $100.51 |
| Revenue Next Year | $109.91 | $79.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1025.95 | 49.22 |
| 52 Week Low | $1.83 | $2.95 |
| 52 Week High | $5.16 | $10.37 |
| Indicator | IBRX | EXK |
|---|---|---|
| Relative Strength Index (RSI) | 58.44 | 70.00 |
| Support Level | $2.05 | $6.91 |
| Resistance Level | $2.18 | $7.97 |
| Average True Range (ATR) | 0.13 | 0.58 |
| MACD | 0.03 | 0.18 |
| Stochastic Oscillator | 83.00 | 95.99 |
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.